uric acid has been researched along with Liver Cirrhosis, Biliary in 5 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Liver Cirrhosis, Biliary: FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ursodeoxycholic acid (UDCA) is currently the only available pharmacological treatment for asymptomatic primary biliary cirrhosis (aPBC)." | 7.79 | Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis. ( Dohmen, K; Haruno, M; Tanaka, H, 2013) |
| "Ursodeoxycholic acid (UDCA) is currently the only available pharmacological treatment for asymptomatic primary biliary cirrhosis (aPBC)." | 3.79 | Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis. ( Dohmen, K; Haruno, M; Tanaka, H, 2013) |
| "A 51-year-old woman with primary biliary cirrhosis developed distal renal tubular acidosis and hypouricemia (1." | 1.27 | Hypouricemia and renal tubular acidosis in primary biliary cirrhosis. ( Daiguji, Y; Hasumura, Y; Izumi, N; Sakai, H; Shinohara, S; Takeuchi, J, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohmen, K | 1 |
| Tanaka, H | 1 |
| Haruno, M | 1 |
| Park, EJ | 1 |
| Ko, G | 1 |
| Kim, J | 1 |
| Sohn, DH | 1 |
| Takabatake, T | 1 |
| Ohta, H | 1 |
| Ishida, Y | 1 |
| Hara, H | 1 |
| Ushiogi, Y | 1 |
| Hattori, N | 1 |
| van Waeg, G | 1 |
| Niklasson, F | 1 |
| de Verdier, CH | 1 |
| Izumi, N | 1 |
| Sakai, H | 1 |
| Shinohara, S | 1 |
| Daiguji, Y | 1 |
| Hasumura, Y | 1 |
| Takeuchi, J | 1 |
5 other studies available for uric acid and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.
Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort S | 2013 |
Biotransformation of theophylline in cirrhotic rats induced by biliary obstruction.
Topics: Animals; Area Under Curve; Biotransformation; Body Weight; Bronchodilator Agents; Cholestasis; Half- | 1999 |
Low serum creatinine levels in severe hepatic disease.
Topics: Creatinine; Glomerular Filtration Rate; Humans; Inulin; Kidney; Liver Cirrhosis, Biliary; Liver Dise | 1988 |
Deamination of guanine to xanthine: a metabolic pathway of underestimated importance in human purine catabolism?
Topics: Allopurinol; Female; Gilbert Disease; Guanine; Humans; Kinetics; Liver Cirrhosis, Biliary; Male; Ref | 1986 |
Hypouricemia and renal tubular acidosis in primary biliary cirrhosis.
Topics: Acidosis, Renal Tubular; Female; Humans; Hypoxanthine; Hypoxanthines; Liver Cirrhosis, Biliary; Midd | 1985 |